Rank;Global Rank;Institution;Country;Sector
1;31;Samsung Corp *;MUL;Companies
2;85;MedImmune, LLC.;USA;Companies
3;94;Toyota Group *;MUL;Companies
4;103;F Hoffmann-La Roche *;MUL;Companies
5;120;Regeneron Pharmaceuticals Inc;USA;Companies
6;126;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
7;127;IBM United States;USA;Companies
8;128;Hoffmann-La Roche Ltd, United States;USA;Companies
9;134;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
10;140;Novartis Institutes for Biomedical Research, United States;USA;Companies
11;141;Genentech Inc;USA;Companies
12;147;AstraZeneca *;MUL;Companies
13;161;Bristol-Myers Squibb Company, United States;USA;Companies
14;168;Alphabet Inc *;MUL;Companies
15;174;Bristol-Myers Squibb Company *;MUL;Companies
16;177;GlaxoSmithKline *;MUL;Companies
17;180;Novartis *;MUL;Companies
18;185;Merck *;MUL;Companies
19;186;Sumitomo Group *;MUL;Companies
20;187;Biogen Idec, USA;USA;Companies
21;192;Siemens *;MUL;Companies
22;201;Biogen Idec *;MUL;Companies
23;207;Sanofi, United States;USA;Companies
24;217;Johnson & Johnson *;MUL;Companies
25;219;Merck & Co Inc, United States;USA;Companies
26;220;GlaxoSmithKline, United States;USA;Companies
27;221;AstraZeneca, United Kingdom;GBR;Companies
28;222;Sanofi *;MUL;Companies
29;233;Siemens AG, Germany;DEU;Companies
30;236;Pfizer *;MUL;Companies
30;236;IBM Research *;MUL;Companies
32;239;Pfizer Inc, United States;USA;Companies
33;246;Gilead Sciences Inc, United States;USA;Companies
34;247;Janssen;MUL;Companies
35;248;Gilead Sciences *;MUL;Companies
36;254;BMJ Group;GBR;Companies
37;260;General Electric Company *;MUL;Companies
37;260;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies
39;265;Hitachi *;MUL;Companies
40;268;Janssen Biotech Inc;USA;Companies
41;273;Amgen, USA;USA;Companies
42;276;Amgen *;MUL;Companies
43;283;Merck KGaA, Germany;DEU;Companies
44;286;Eli Lilly and Company, United States;USA;Companies
45;289;Boehringer Ingelheim *;MUL;Companies
46;292;AstraZeneca, United States;USA;Companies
47;299;Robert Bosch *;MUL;Companies
48;302;Novo Nordisk *;MUL;Companies
49;303;Eli Lilly *;MUL;Companies
50;309;GlaxoSmithKline, United Kingdom;GBR;Companies
51;312;Novo Nordisk A/S;DNK;Companies
52;313;Bayer *;MUL;Companies
53;321;Janssen Research & Development, LLC;BEL;Companies
54;325;Boehringer Ingelheim, USA;USA;Companies
55;332;Boehringer Ingelheim GmbH Germany;DEU;Companies
56;333;Celgene Corp;USA;Companies
57;335;Koninklijke Philips NV *;MUL;Companies
58;336;Siemens AG, USA;USA;Companies
59;338;Bayer AG, Germany;DEU;Companies
60;363;AbbVie *;MUL;Companies
61;364;AbbVie Inc, United States;USA;Companies
62;382;Takeda Pharmaceuticals International Inc, USA;USA;Companies
63;392;Philips Research, Eindhoven;NLD;Companies
64;399;Takeda Pharmaceuticals International Inc *;MUL;Companies
65;406;Novartis, Switzerland;CHE;Companies
65;406;VTT Technical Research Centre of Finland;FIN;Companies
67;427;Daiichi Sankyo Co., Ltd. Japan;JPN;Companies
68;434;Danone *;MUL;Companies
69;439;UCB Pharma SA *;MUL;Companies
70;440;DowDupont *;MUL;Companies
71;441;AstraZeneca, Sweden;SWE;Companies
72;442;GlaxoSmithKline, Belgium;BEL;Companies
73;443;Shionogi & Co Ltd;JPN;Companies
74;451;Danone Nederland BV;NLD;Companies
75;453;BASF Group *;MUL;Companies
76;456;BASF, Germany;DEU;Companies
77;457;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
78;458;Siemens Healthineers, USA;USA;Companies
79;465;Novartis Pharmaceuticals, United States;USA;Companies
80;469;GE Healthcare;MUL;Companies
81;470;Daiichi Sankyo Co., Ltd. *;MUL;Companies
82;472;Takeda Pharmaceutical Co Inc, Japan;JPN;Companies
83;480;Syngenta *;MUL;Companies
84;494;Nestle Switzerland;CHE;Companies
85;495;Medtronic *;MUL;Companies
86;500;Translational Research Institute;AUS;Companies
87;501;Nestle *;MUL;Companies
87;501;Bayer Corp, USA;USA;Companies
89;520;Pfizer Inc, United Kingdom;GBR;Companies
90;531;UCB Pharma SA, Brussels;BEL;Companies
91;537;Unilever *;MUL;Companies
92;539;Lockheed Martin Corp *;USA;Companies
93;555;SINTEF Group;NOR;Companies
94;557;Astellas Pharma Inc;JPN;Companies
95;560;GeneDx;USA;Companies
96;572;Allergan plc *;MUL;Companies
96;572;Allergan plc, USA;USA;Companies
98;597;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
99;606;Springer Nature, New Zealand;NZL;Companies
99;606;Springer Nature *;MUL;Companies
101;618;RTI Health Solutions;USA;Companies
102;620;Johnson & Johnson, United States;USA;Companies
103;630;IMEC International;BEL;Companies
104;643;Abbott Laboratories *;MUL;Companies
105;652;Manipal Global Education Group *;MUL;Companies
106;656;EMMES Corp;USA;Companies
107;658;Nippon Telegraph and Telephone Corp, Japan;JPN;Companies
108;701;Elsevier, France;FRA;Companies
109;723;ARUP Laboratories;USA;Companies
110;736;Pharmaceutical Product Development LLC;USA;Companies
111;768;Nippon Telegraph and Telephone Corporation *;MUL;Companies
112;817;GE Healthcare China Co Ltd;CHN;Companies
113;854;Estacio Participacoes SA *;BRA;Companies
114;916;RELX Group plc *;MUL;Companies